 Collegium Pharmaceutical Inc NASDAQ: COLL reported Q2 adjusted EPS of 0.27, below the consensus of 0.36. The reported EPS of 1.79 was up from 0.23 a year ago and included a one-time non-cash adjustment of 1.52 per share. 